Clinical Trial Update: Topical Keratin in Treating Radiation Dermatitis in Patients With Breast Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluated topical keratin for treating radiation dermatitis in breast cancer patients. The results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Radiation-induced Dermatitis

Drugs mentioned

• Topical Keratin (keratin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Breast Carcinoma, Radiation-Induced Dermatitis | NA | Status: COMPLETED | Results posted: 2020-02-12